Peer Exchange

Clinical Evidence of Insulin Degludec in Type 2 Diabetes
September 05, 2017 – 
Mark Warren, MD, reviews the clinical trial evidence with insulin degludec in type 2 diabetes, highlighting the recent DEVOTE trial and what it adds to the SWITCH study findings.
Diabetes: Shifting the Mindset for Cardiovascular Benefits
August 30, 2017 – 
John Anderson, MD, reviews data from the EMPA-REG OUTCOME trial with empagliflozin and discusses the impact the findings had on the diabetes field.
Complexities in Diabetes Care in 2017
August 30, 2017 – 
John Anderson, MD, discusses the complexities involved in the management of diabetes and highlights the key factors to consider.
Formulary Access to Insulins in Type 2 Diabetes
August 29, 2017 – 
Mark Warren, MD, emphasizes the importance of formulary access to the insulin therapies prescribed and the role of biosimilar insulins in type 2 diabetes.
Deciding Among Insulin Therapies for Type 2 Diabetes
August 29, 2017 – 
Mark Warren, MD, explains some of the key benefits associated with the ultra–long acting insulins and shares his clinical rationale for switching therapies in type 2 diabetes.
Practical Decisions in Type 2 Diabetes
August 22, 2017 – 
Mark Warren, MD, shares how he makes type 2 diabetes treatment decisions and explains the link between regimen complexity, compliance, and resource utilization.
Barriers to Insulin Therapy in Type 2 Diabetes
August 22, 2017 – 
Mark Warren, MD, provides an overview of some of the key barriers to initiating insulin therapy in patients with type 2 diabetes.
Role of GLP-1/Insulin Combinations
August 15, 2017 – 
Louis S. Christos, RPh, offers a payer perspective regarding the role of glucagon-like peptide-1 receptor agonist/insulin combinations and discusses the importance of real world evidence.
The Future of Healthcare in the United States
August 14, 2017 – 
Panelists Joseph Alvarnas, MD; Robert Carlson, MD; Elizabeth Carpenter; and John Fox, MD, provide further expectations for the future of value-based oncology care.
How Will an ACA Repeal Affect Healthcare?
August 14, 2017 – 
Leonard Lichtenfeld, MD, shares insight on the impact of repealing the Affordable Care Act.
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome to the new and improved, the premier managed markets network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!